健友股份(603707.SH)子公司产品盐酸罗哌卡因注射液获美国FDA批准

智通财经网07-31

智通财经APP讯，健友股份(603707.SH)发布公告，公司子公司健进制药有限公司(简称“健进制药”)于近日收到美国食品药品监督管理局(简称“美国FDA”)签发的盐酸罗哌卡因注射液，USP，20mg/10mL(2mg/mL),40mg/20mL(2mg/mL),100mg/20mL(5mg/mL),150mg/30mL(5mg/mL),100mg/10mL(10mg/mL),200mg/20mL...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2455597730?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-07-31 15:47","share_image_url":"https://static.laohu8.com/6ca2dcdccfa2217fb20a0351f4efe814","id":"2455597730","market":"sh","top_or_hot":-1,"title":"健友股份(603707.SH)子公司产品盐酸罗哌卡因注射液获美国FDA批准","media":"智通财经网","content":"<div>\n<p>智通财经APP讯，健友股份(603707.SH)发布公告，公司子公司健进制药有限公司(简称“健进制药”)于近日收到美国食品药品监督管理局(简称“美国FDA”)签发的盐酸罗哌卡因注射液，USP，20mg/10mL(2mg/mL),40mg/20mL(2mg/mL),100mg/20mL(5mg/mL),150mg/30mL(5mg/mL),100mg/10mL(10mg/mL),200mg/20mL...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1157920.html\">网页链接</a>\n\n</div>\n","source":"highlight_zhitongcaijin","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>健友股份(603707.SH)子公司产品盐酸罗哌卡因注射液获美国FDA批准</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n健友股份(603707.SH)子公司产品盐酸罗哌卡因注射液获美国FDA批准\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-07-31 15:47 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1157920.html><strong>智通财经网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，健友股份(603707.SH)发布公告，公司子公司健进制药有限公司(简称“健进制药”)于近日收到美国食品药品监督管理局(简称“美国FDA”)签发的盐酸罗哌卡因注射液，USP，20mg/10mL(2mg/mL),40mg/20mL(2mg/mL),100mg/20mL(5mg/mL),150mg/30mL(5mg/mL),100mg/10mL(10mg/mL),200mg/20mL...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1157920.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"医药制造","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1157920.html","article_id":"2455597730","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2455597730","pubTimestamp":1722412043,"sourceInfo":{"source_id":"highlight_zhitongcaijin","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，健友股份 发布公告，公司子公司健进制药有限公司于近日收到美国食品药品监督管理局签发的盐酸罗哌卡因注射液，USP，20mg/10mL,40mg/20mL,100mg/20mL,150mg/30mL,100mg/10mL,200mg/20mL和150mg/20mL的ANDA批准通知。盐酸罗哌卡因注射液适用于外科手术麻醉和急性疼痛控制。新批准产品近期将安排在美国上市销售，有望对公司经营业绩产生积极影响。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"603707":"健友股份","BK0239":"医药制造","BK0186":"小盘成长","BK0046":"生物疫苗"},"translate_title":"Ropivacaine Hydrochloride Injection, a subsidiary product of Jianyou Co., Ltd. (603707. SH), was approved by the US FDA","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"603707":1},"content_text":"智通财经APP讯，健友股份(603707.SH)发布公告，公司子公司健进制药有限公司(简称“健进制药”)于近日收到美国食品药品监督管理局(简称“美国FDA”)签发的盐酸罗哌卡因注射液，USP，20mg/10mL(2mg/mL),40mg/20mL(2mg/mL),100mg/20mL(5mg/mL),150mg/30mL(5mg/mL),100mg/10mL(10mg/mL),200mg/20mL(10mg/mL)和150mg/20mL(7.5mg/mL)的ANDA批准通知(ANDA号：218713)。盐酸罗哌卡因注射液适用于外科手术麻醉和急性疼痛控制。新批准产品近期将安排在美国上市销售，有望对公司经营业绩产生积极影响。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2455597730"}